In Challenging Times, Sanofi’s Viehbacher Explores New Pricing Models In Emerging Markets

01 Oct 2013

• By Vikas Dandekar

In a rare spotlight opportunity, Sanofi CEO Christopher Viehbacher shares his views on emerging markets during a visit to Mumbai.

MUMBAI – Sanofi CEO Christopher Viehbacher visited India on Monday, Sept. 30, at a time when the industry faces tough challenges in emerging markets, be it pricing pressures and graft charges in China, or the impact of India’s new drug pricing policy.

Viehbacher delivered a keynote address during the 47th Annual General Meeting of the Organization of Pharmaceutical Producers of India, which...